🇺🇸 FDA
Patent

US 11111310

Chimeric polypeptides and methods of altering the membrane localization of the same

granted A61KA61K2039/5156A61K2039/5158

Quick answer

US patent 11111310 (Chimeric polypeptides and methods of altering the membrane localization of the same) held by Cell Design Labs, Inc. expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cell Design Labs, Inc.
Grant date
Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K2039/5156, A61K2039/5158, A61K2239/11, A61K2239/22